IHH Healthcare Berhad

SGX:Q0F Stock Report

Market Cap: S$19.0b

IHH Healthcare Berhad Valuation

Is Q0F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of Q0F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
S$3.66
Fair Value
41.3% undervalued intrinsic discount
21
Number of Analysts

Below Fair Value: Q0F (SGD2.15) is trading below our estimate of fair value (SGD3.66)

Significantly Below Fair Value: Q0F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for Q0F?

Key metric: As Q0F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for Q0F. This is calculated by dividing Q0F's market cap by their current earnings.
What is Q0F's PE Ratio?
PE Ratio23.5x
EarningsRM 2.65b
Market CapRM 62.22b

Price to Earnings Ratio vs Peers

How does Q0F's PE Ratio compare to its peers?

The above table shows the PE ratio for Q0F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average33.5x
A50 Thomson Medical Group
83.9x14.4%S$1.3b
BSL Raffles Medical Group
25.5x12.2%S$1.6b
40T ISEC Healthcare
16.6xn/aS$230.1m
EHG Econ Healthcare (Asia)
8.2xn/aS$66.5m
Q0F IHH Healthcare Berhad
23.5x0.5%S$62.2b

Price-To-Earnings vs Peers: Q0F is good value based on its Price-To-Earnings Ratio (23.5x) compared to the peer average (33.5x).

Price to Earnings Ratio vs Industry

How does Q0F's PE Ratio compare vs other companies in the Asian Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Q0F 23.5xIndustry Avg. 20.9xNo. of Companies57PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: Q0F is expensive based on its Price-To-Earnings Ratio (23.5x) compared to the Asian Healthcare industry average (20.9x).

Price to Earnings Ratio vs Fair Ratio

What is Q0F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Q0F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.5x
Fair PE Ratio30.3x

Price-To-Earnings vs Fair Ratio: Q0F is good value based on its Price-To-Earnings Ratio (23.5x) compared to the estimated Fair Price-To-Earnings Ratio (30.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst Q0F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentS$2.15
S$2.44
+13.5%
7.1%S$2.76S$2.10n/a21
Jan ’26S$2.19
S$2.44
+11.4%
7.1%S$2.76S$2.10n/a21
Dec ’25S$2.19
S$2.40
+9.6%
6.9%S$2.74S$2.14n/a21
Nov ’25S$2.21
S$2.34
+6.0%
5.9%S$2.68S$2.10n/a21
Oct ’25S$2.23
S$2.36
+5.7%
5.6%S$2.74S$2.14n/a21
Sep ’25S$1.91
S$2.26
+18.1%
5.6%S$2.42S$1.93n/a21
Aug ’25S$1.85
S$2.11
+13.8%
6.0%S$2.31S$1.85n/a21
Jul ’25S$1.81
S$2.09
+15.4%
6.2%S$2.30S$1.84n/a21
Jun ’25S$1.78
S$2.07
+16.5%
6.0%S$2.27S$1.84n/a20
May ’25S$1.81
S$2.04
+12.5%
6.4%S$2.25S$1.83n/a20
Apr ’25S$1.73
S$2.02
+16.9%
6.4%S$2.23S$1.81n/a20
Mar ’25S$1.73
S$2.00
+15.9%
6.4%S$2.23S$1.75n/a19
Feb ’25S$1.72
S$2.00
+16.1%
6.3%S$2.19S$1.79n/a18
Jan ’25S$1.73
S$2.01
+16.2%
6.3%S$2.21S$1.81S$2.1917
Dec ’24S$1.68
S$2.00
+18.9%
6.1%S$2.20S$1.80S$2.1918
Nov ’24S$1.71
S$2.01
+17.3%
6.2%S$2.21S$1.78S$2.2118
Oct ’24S$1.70
S$2.04
+20.2%
6.0%S$2.24S$1.81S$2.2319
Sep ’24S$1.74
S$2.05
+17.9%
5.9%S$2.25S$1.81S$1.9120
Aug ’24S$1.75
S$2.07
+18.1%
6.0%S$2.25S$1.83S$1.8521
Jul ’24S$1.68
S$2.07
+23.3%
6.1%S$2.26S$1.84S$1.8122
Jun ’24S$1.69
S$2.06
+22.1%
5.5%S$2.23S$1.84S$1.7822
May ’24S$1.71
S$2.13
+24.6%
6.0%S$2.34S$1.89S$1.8121
Apr ’24S$1.72
S$2.13
+23.7%
5.9%S$2.33S$1.89S$1.7321
Mar ’24S$1.73
S$2.15
+24.0%
6.5%S$2.37S$1.89S$1.7320
Feb ’24S$1.82
S$2.20
+20.7%
6.0%S$2.40S$1.94S$1.7220
Jan ’24S$1.89
S$2.22
+17.7%
6.0%S$2.43S$1.96S$1.7321
Analyst Price Target
Consensus Narrative from 21 Analysts
S$2.45
Fair Value
12.1% undervalued intrinsic discount
21
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 22:32
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IHH Healthcare Berhad is covered by 40 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chee ChowAffin Hwang Investment Bank
Lik Hsin AwAffin Hwang Investment Bank
Ken-Wern LimAffin Hwang Investment Bank